#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adult T-cell lymphoma/leukaemia refractory Transitional cell carcinoma Renal cancer metastatic Acquired ATTR amyloidosis Haemophilia Noonan syndrome Neoplasm Myxoid liposarcoma Paroxysmal nocturnal haemoglobinuria Peripheral T-cell lymphoma unspecified Acute promyelocytic leukaemia Kidney transplant rejection Diffuse large B-cell lymphoma Emphysema Familial haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Netherton’s syndrome – Life with Disease Ocular melanoma – Treatment Acquired haemophilia – Life with Disease Metachromatic leukodystrophy – Treatment Kearns-Sayre syndrome – Trials in Disease Idiopathic pulmonary fibrosis – Trials in Disease Ewing’s sarcoma recurrent – Trials in Disease Alport’s syndrome – Basic Information Marginal zone lymphoma Mastocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paltusotine CAL101 Aluminium Oxide, Hydrated GS-4321 Corylus Avellana L. Asfotase Alfa Liquid Paraffin VRDN-003 Azd4831 Heparin Calcium Oleclumab Colchicine AMG 732 Povetacicept Sulodexide Glucagon Cenerimod Protrans Atrasentan Hydrochloride Vepdegestrant More therapies…

    Learn about Your Condition

    Malignant peritoneal neoplasm Astrocytoma malignant Palmoplantar pustulosis Lysosomal storage disorder Muscle injury Hypoalbuminaemia Uterine cancer Haematological infection Hairy cell leukaemia Dementia with Lewy bodies Pulmonary venous thrombosis Substance use disorder HER2 positive gastric cancer Myeloproliferative neoplasm Squamous cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Esketamine and Aripiprazole with Antidepressants for Treatment-Resistant Depression in Elderly Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aripiprazole
    • Esketamine
    Spain

  • Esketamine Nasal Spray for Patients with Treatment-Resistant Bipolar Depression

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Esketamine
    The Netherlands

  • Study of daridorexant and buprenorphine combination treatment for patients with opioid use disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Buprenorphine
    • Naloxone
    • Daridorexant
    Sweden

  • Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Clemastine
    • Placebo
    Germany

  • Comparing Buprenorphine/Naloxone and Methadone for Opioid Use Disorder in Patients with Chronic Pain: A Study on Reducing Opioid Misuse

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Drug use disorder
    • Pain
    Investigated Drugs:
    • Buprenorphine
    • Methadone Hydrochloride
    • Naloxone
    The Netherlands

  • Study Comparing Lithium and Cariprazine for Treating Bipolar Depression in Patients with Bipolar Type 1 or 2 During a Depressive Episode

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Cariprazine
    Denmark
Previous Page
1 … 10 11 12 13 14 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!